Get started
Medipharm Labs CorporationMedipharm Labs CorporationMedipharm Labs Corporation

Medipharm Labs Corporation

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

MEDIF trade ideas

MediPharm Labs bullish on new contract.MediPharm Labs' (OTCQX:MEDIF) Australian subsidiary has entered a private label sales and manufacturing agreement with a Licensed Producer in Australia and taken other important steps to advance its early leadership in the Australian and Asia-Pacific extraction market. Under the terms of the manufacturing agreement, MediPharm Labs Australia will purchase dried flower and sell high quality, private-label cannabis oil and manufactured products. The agreement has a 12-month term with options to extend. MediPharm Labs Australia has also successfully negotiated multi-year supply agreements with three Australian Office of Drug Control approved cultivators. Source Seeking Alpha COMPANY PROFILE MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
OTC:MEDIFLong
by OTCMarketsExpert
Medipharm Labs (LABS.TO) Forming Rounded Continuation for SetupThis stock has had an amazing run already, and it is setting up again. The stock has formed a rounded bottom continuation pattern. I don't have a trade in this one currently, but since it is a rounded bottom I will wait for the next pullback. This has nothing to do with trying to get a better price. Rather, I want to see the pullback stay above the prior consolidation/swing low and then move higher. This helps confirm the price is still in a rounded bottom continuation pattern and likely to head higher. Also, earnings are due out August 12. No point taking a trade right before. I'd rather wait for earnings and see what kind of setup we get. NO TRADE YET. Since this stock has been exceptionally strong, I will utilize a trailing stop loss (based on ATR, indicator shown on chart). I utilize the CLOSING price method discussed in this article: vantagepointtrading.com
TSX:LABSLong
by CoryMitchell-CMT
7